COMPANY PROFILE · UPDATED 18 NOV 2025

InterVenn Biosciences

InterVenn focuses on the identification, quantification, and classification of Glycoproteomic and other PTM signals found in human blood and tissue for biomarker and target discovery. It specializes in the fields of biotechnology and life…

intervenn.bio ↗

This profile is unclaimed — do you work here? Claim it

Claim it →

Founded: 2017
Headcount: 167
Open roles: 0
Last raised: Series C · Sign in to view

LEADERSHIP

Founders & key people

Aldo Carrascoso

CTO at Veem

VeemInterVenn BiosciencesJukin MediaCoalescent ResourcingJukinVideoVeregoBabson F.W. Olin Graduate School of BusinessBabson CollegeAteneo de Manila University

Carolyn Bertozzi

American chemist

StanfordInterVenn BiosciencesElysium HealthUniversity of California BerkeleyUCSFPalleon PharmaceuticalsUniversity of California BerkeleyHarvardLexington High SchoolUCSF

Carlito B Lebrilla

Lieza Danan

CEO at LiVeritas Biosciences

LiVeritas BiosciencesFreelanceIntabioInterVenn BiosciencesStemcentrxSF Bay Area Ateneans (Ateneo de Manila Alumni Group)University of California DavisAteneo de Manila UniversityManila Science High School

OPEN ROLES

Roles at InterVenn Biosciences

Employbl doesn’t track InterVenn Biosciences’s job board yet, so there’s nothing to show here — they may still be hiring. You can also search all jobs →

FUNDING

Capital raised

Total raised

$244,400,000

Investors

True VenturesAmplify PartnersAnzu PartnersBoost VCGenoa VenturesHeritage Provider NetworkHighside Capital ManagementIrving InvestorsOjjeh Family FundPRADO SVSoftBank Groupxeraya capital

Funding rounds

Series C
SoftBank Group, Highside Capital Management, Irving Investors, True Ventures, Anzu Partners, Amplify Partners, Genoa Ventures, Heritage Provider Network
$201MAug 1, 2021
Series B
Anzu Partners, Amplify Partners, xeraya capital, True Ventures, Genoa Ventures, Ojjeh Family Fund
$34MNov 15, 2020
Series Unknown
Genoa Ventures, PRADO SV, Boost VC, True Ventures, Amplify Partners
$9.4MDec 11, 2018